Alembic Pharmaceuticals net profit rises 110.11% in the March 2013 quarter
Capital MarketNet profit of Alembic Pharmaceuticals rose 110.11% to Rs 39.71 crore in the quarter ended March 2013 as against Rs 18.90 crore during the previous quarter ended March 2012. Sales rose 18.77% to Rs 376.23 crore in the quarter ended March 2013 as against Rs 316.76 crore during the previous quarter ended March 2012.
For the Audited full year,net profit rose 30.62% to Rs 157.45 crore in the year ended March 2013 as against Rs 120.54 crore during the previous year ended March 2012. Sales rose 8.63% to Rs 1489.54 crore in the year ended March 2013 as against Rs 1371.25 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales376.23316.76
19 1489.541371.25
9 OPM %16.4012.39
32 16.3615.21
8 PBDT59.9534.27
75 233.12183.81
27 PBT51.3125.35
102 198.16150.16
32 NP39.7118.90
110 157.45120.54
31 Powered by Capital Market - Live News
